Source: FDA · July 28, 2026 · Ongoing · Official government notice
FDA analysis revealed the presence of unapproved ingredients including tianeptine, 1,4 DMAA, and aniracetam. The recalled product was distributed to customers nationwide from April 2022 until December 8, 2025
